CALYPTE BIOMEDICAL CORP Diluted Shares Outstanding (Weighted Average)
CALYPTE BIOMEDICAL CORP reported Diluted Shares Outstanding (Weighted Average) of 700.17 million shares for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-12-31.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2012-12-31
- CALYPTE BIOMEDICAL CORP weighted average number of shares outstanding, diluted for the quarter ending 2012-09-30 was 700.17M shares, a 27.81% increase year-over-year.
- CALYPTE BIOMEDICAL CORP weighted average number of shares outstanding, diluted for the quarter ending 2012-06-30 was 700.17M shares, a 27.81% increase year-over-year.
- CALYPTE BIOMEDICAL CORP weighted average number of shares outstanding, diluted for the quarter ending 2012-03-31 was 566.24M shares, a 4.89% increase year-over-year.
- CALYPTE BIOMEDICAL CORP weighted average number of shares outstanding, diluted for the quarter ending 2011-12-31 was 547.85M shares, a 6.62% increase year-over-year.
- CALYPTE BIOMEDICAL CORP weighted average number of shares outstanding, diluted for fiscal 2011 was 545.85M shares, a 11.94% increase from fiscal 2010.
- CALYPTE BIOMEDICAL CORP weighted average number of shares outstanding, diluted for fiscal 2010 was 487.62M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2012-09-30 | 700.17M shares 10-Q · filed 2012-12-31 | 700.17M shares derived: average of 2 quarters · filed 2012-12-31 | 655.69M shares 10-Q · filed 2012-12-31 | 628.61M shares derived: average of 4 quarters · filed 2012-12-31 |
| 2012-06-30 | 700.17M shares 10-Q · filed 2012-08-14 | 633.21M shares 10-Q · filed 2012-08-14 | 604.75M shares derived: average of 3 quarters · filed 2012-08-14 | 590.52M shares derived: average of 4 quarters · filed 2012-12-31 |
| 2012-03-31 | 566.24M shares 10-Q · filed 2012-05-15 | 557.04M shares derived: average of 2 quarters · filed 2012-05-15 | 553.97M shares derived: average of 3 quarters · filed 2012-12-31 | 552.44M shares derived: average of 4 quarters · filed 2012-12-31 |
| 2011-12-31 | 547.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-22 | 547.84M shares derived: average of 2 quarters · filed 2012-12-31 | 547.83M shares derived: average of 3 quarters · filed 2012-12-31 | 545.85M shares 10-K · filed 2012-03-22 |
| 2011-09-30 | 547.83M shares 10-Q · filed 2012-12-31 | 547.83M shares derived: average of 2 quarters · filed 2012-12-31 | 545.19M shares 10-Q · filed 2012-12-31 | 537.33M shares derived: average of 4 quarters · filed 2012-12-31 |
| 2011-06-30 | 547.83M shares 10-Q · filed 2012-08-14 | 543.85M shares 10-Q · filed 2012-08-14 | 533.84M shares derived: average of 3 quarters · filed 2012-08-14 | 523.52M shares derived: average of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | 539.83M shares 10-Q · filed 2012-05-15 | 526.84M shares derived: average of 2 quarters · filed 2012-05-15 | 515.42M shares derived: average of 3 quarters · filed 2012-05-15 | 505.90M shares derived: average of 4 quarters · filed 2012-05-15 |
| 2010-12-31 | 513.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-22 | 503.21M shares derived: average of 2 quarters · filed 2012-03-22 | 494.59M shares derived: average of 3 quarters · filed 2012-03-22 | 487.62M shares 10-K · filed 2012-03-22 |
| 2010-09-30 | 492.57M shares 10-Q · filed 2012-01-27 | 484.96M shares derived: average of 2 quarters · filed 2012-01-27 | 478.87M shares 10-Q · filed 2012-01-27 | |
| 2010-06-30 | 477.34M shares 10-Q/A · filed 2011-11-30 | 471.90M shares 10-Q/A · filed 2011-11-30 |